Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

ImmunoCellular Therapeutics Ltd.

AMEX: IMUCHealthcare / Biotechnology / USA
0.27+0.01+3.85%Vol 323 6571Y Perf -76.45%
May 25th, 2018 16:00
BID0.26 ASK0.27
Open0.27 Previous Close0.27
Pre-Market- After-Trading-
 - -%  - -%
Target Price
5.00 
Analyst Rating
Hold 3.00
Potencial %
1 751.85 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)11 
Earnings Rating
Price Range Ratio 52wk %
8.70 
Earnings Date

Today's Price Range

0.260.27

 

52wk Range

0.032.79

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Month
3.85%
3 Months
0.00%
6 Months
-12.90%
1 Year
-76.45%
3 Years
-42.68%
5 Years
-89.53%
Last Quotes
Name / TickerPriceChg.Chg.%
IMUC0.270.01003.85
AAPL188.580.43000.23
GOOG1 075.66-3.5800-0.33
MSFT98.360.05000.05
XOM78.71-1.5600-1.94
WFC54.900.23000.42
JNJ121.470.12000.10
FB184.92-1.0100-0.54
GE14.630.03000.21
JPM110.66-0.5700-0.51
...

TickerPriceChg.%52 Week High
FL55.7420.1660.64
DGX105.814.88112.96
LH182.143.84184.33
LEN53.393.7572.17
ALK61.873.3495.75
LUV52.863.2266.99
AAL44.913.1059.08
RCL109.802.91135.65
K65.232.7174.28
DAL55.872.7060.79
AVGO250.032.67285.68
UA18.882.6621.81
INCY68.432.64140.11
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 3.40
Current Ratio 3.50
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -20.90
Leverage Ratio 4.90
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-
EBITDA Margin-
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 3.20
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -1.00
Cash Flow Per Share -0.51
Price to Tangible Book3.20
Book Value per Share0.09
Enterprise Value (in ths.)6 713
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-76.84
ROE last 12 Months -615.81
Return on Assets (5Y Avg) -179.42
ROA last 12 Months -163.09
Return on Capital (5Y Avg) -118.15
ROC last 12 Months -595.14
Return on invested Capital Q -24.64
Return on invested Capital Y-311.75
Assets Turnover0.00
Receivables Turnover-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)0
Revenue per Share 0.00
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q03 2016-2.00-1.6020.00
Q02 2016-2.80-2.4014.29
Q01 2016-2.80-2.800.00
Q04 2015-1.60-2.40-50.00
Q03 2015-1.60-1.600.00
Q02 2015-0.03-0.030.00
Q01 2015-0.02-0.04-100.00
Q04 2014-0.05-0.0420.00
Earnings Per EndEstimateRevision %Trend
12/2016 QR-1.7626.67Positive
12/2016 FY-6.7011.84Positive
12/2017 FY-8.572.61Positive
----
Next Report Date21st May 2018
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume323 657
Shares Outstanding (in ths.)41 930
Trades Count218
Dollar Volume86 051
Avg. Volume1 123 493
Avg. Weekly Volume232 251
Avg. Monthly Volume428 418
Avg. Quarterly Volume962 926

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

60%40%

Bearish Bullish

55%45%

Bearish Bullish

58%42%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingHold
3.00
Hold
3.00
Hold
3.00

There are no comments yet.

News

x